anyaberkut/iStock via Getty Images European activist fund Petrus Advisers disclosed a stake in French adtech firm Criteo (NASDAQ:CRTO) on Friday. Petrus Advisers unveiled a more than 5% stake in Criteo (CRTO) Friday near the close...
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from...
sasirin pamai The Federal Reserve should hold rates as they are, not lower them, said Paul Hickey, Bespoke Investment Group co-founder. In a CNBC interview, he said that the best thing for the market would...
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from...
Anna Moneymaker U.S. stocks on Friday pushed higher, overcoming a knee-jerk reaction to hawkish opening comments from Federal Reserve chair Jerome Powell at an event. Market participants remain convinced that recent favorable inflation data means...
Grafissimo/E+ via Getty Images Crescent Energy (NYSE:CRGY) +2.7% in Friday's trading as Evercore ISI initiated coverage with an Outperform rating and $16 price target, seeing "an attractive entry point for investors, with shares trading at...
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from...
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from...
syahrir maulana/iStock via Getty Images The U.S. Food and Drug Administration (FDA) on Wednesday granted its orphan drug designation for an experimental therapy developed by Edgewise Therapeutics (NASDAQ:EWTX) for two rare forms of muscular...
